益生元预防急性移植物抗宿主病并维持肠道菌群
该前瞻性研究在异基因造血干细胞移植受者中,从预处理期至移植后28天给予抗性淀粉和商品化益生元混合物GFO,发现益生元摄入可减轻黏膜损伤、降低所有级别及2-4级急性GVHD累积发生率,并维持肠道微生物多样性和产丁酸菌群。
要点
- 益生元摄入降低所有级别及2-4级急性GVHD发生率。
- 益生元摄入显著降低皮肤急性GVHD累积发生率。
- 益生元维持肠道微生物多样性和产丁酸菌群,移植后粪便丁酸浓度更常维持或升高。
核心结论
- 益生元摄入可能是预防allo-HSCT后急性GVHD的有效策略,从而改善治疗结局和干细胞移植的临床效用。
研究设计与样本
- 前瞻性研究,在allo-HSCT受者中从预处理期至移植后28天给予抗性淀粉和商品化益生元混合物GFO。
主要发现
- 益生元摄入减轻黏膜损伤,降低所有级别急性GVHD及2-4级急性GVHD的发生率。
- 益生元摄入显著降低皮肤急性GVHD的累积发生率。
- 益生元摄入良好维持肠道微生物多样性并保留产丁酸细菌种群。
- 益生元组移植后粪便丁酸浓度更频繁地维持或升高。
临床怎么用
- 在allo-HSCT受者中,从预处理期至移植后28天给予抗性淀粉和GFO可能有助于预防急性GVHD并维持肠道菌群。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Acute graft-versus-host disease (aGVHD) is a major cause of morbidity and mortality after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Therefore, management of aGVHD is important for successful transplantation. Mucosal damage and alteration of the gut microbiota after allo-HSCT are key factors in the development of aGVHD. We conducted a prospective study to evaluate the ability of prebiotics, which can alleviate mucosal damage and manipulate the gut microbiota, to mitigate posttransplantation complications, including aGVHD. Resistant starch (RS) and a commercially available prebiotics mixture, GFO, were administered to allo-HSCT recipients from pretransplantation conditioning to day 28 after allo-HSCT. Prebiotic intake mitigated mucosal injury and reduced the incidence of all aGVHD grades combined and of aGVHD grades 2 to 4. The cumulative incidence of skin aGVHD was markedly decreased by prebiotics intake. Furthermore, the gut microbial diversity was well maintained and butyrate-producing bacterial population were preserved by prebiotics intake. In addition, the posttransplantation fecal butyrate concentration was maintained or increased more frequently in the prebiotics group. These observations indicate that prebiotic intake may be an effective strategy for preventing aGVHD in allo-HSCT, thereby improving treatment outcomes and the clinical utility of stem cell transplantation approaches. This study was registered on the University Hospital Medical Information Network (UMIN) clinical trials registry (https://www.umin.ac.jp/ctr/index.htm) as #UMIN000027563.
引用
- Yoshifuji K, Inamoto K, Kiridoshi Y, et al. Prebiotics protect against acute graft-versus-host disease and preserve the gut microbiota in stem cell transplantation. Blood Adv. 2020. PMID: 32991720. doi:10.1182/bloodadvances.2020002604
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。